SELLAS Life Sciences Presents Poster at 2022 SOHO Meeting Highlighting Bioequivalence Data for…
GFH009 Formulation is Near Physiological pH, While Still Achieving Desired Effect -GFH009 at pH 6.0 Decreased Potential for Infusion Reaction and Made Dosing Better Tolerated After Multiple Doses or Long-time Infusion - NEW YORK,…